Vaccine, influenza


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intradermal
Active immunisation against influenza
Adult: 18-64 years As inactivated quadrivalent influenza vaccine: 9 mcg as 1 dose per season.

Nasal
Active immunisation against influenza
Adult: As live, attenuated quadrivalent influenza vaccine: ≤49 years 0.2 mL (0.1 mL in each nostril) as 1 dose per season.
Child: As live, attenuated tetravalent influenza vaccine: 2-17 years 0.2 mL (0.1 mL in each nostril), a second dose is given after at least 4 weeks in children who have not been vaccinated previously. As live, attenuated quadrivalent influenza vaccine: 2-8 years 0.2 mL (0.1 in each nostril), a second dose is given after at least 4 weeks in children who have not been vaccinated previously; 9 years Same as adult dose.

Parenteral
Active immunisation against influenza
Adult: As surface antigen, inactivated or split virion, inactivated influenza vaccine: 0.5 mL as 1 dose per season via IM or deep SC inj.
Child: As surface antigen, inactivated influenza vaccine: 6-35 months 0.25 or 0.5 mL as 1 dose per season, in accordance with existing national recommendations; ≥3 years 0.5 mL as 1 dose per season. Repeat dose at least 4 weeks later if child was not previously vaccinated. As split virion, inactivated influenza vaccine: ≥5 years 0.5 mL as 1 dose per season; a 2nd dose should be given after at least 4 weeks in children <9 years who have not been previously vaccinated.
Chống chỉ định
Hypersensitivity to any influenza vaccine, egg or chicken proteins. Severely immunosuppressed patients (e.g. HIV patients). Concomitant salicylate therapy (nasal).
Thận trọng
Patient with asthma, acute illness, recurrent or active wheezing (children <5 years), CV disorders, personal or family history of febrile convulsions, history of Guillain-Barre syndrome; nasal congestion (nasal). Postpone vaccination in patients with active infection or acute febrile illness. Children. Pregnancy and lactation.
Phản ứng phụ
Significant: Syncope, hyperventilation, stress-related reactions, paraesthesia, transient visual disturbance, tonic-clonic limb movements.
Cardiac disorders: Chest tightness.
Gastrointestinal disorders: Sore throat, abdominal pain, gastroenteritis, nausea, vomiting.
General disorders and administration site conditions: Irritability, lethargy, fatigue, weakness, malaise, diaphoresis; injection site reactions (e.g. erythema, bruising, swelling).
Infections and infestations: Infection, varicella.
Metabolism and nutrition disorders: Decreased appetite.
Musculoskeletal and connective tissue disorders: Myalgia, chills, arthralgia, back pain.
Nervous system disorders: Headache, migraine.
Psychiatric disorders: Drowsiness.
Respiratory, thoracic and mediastinal disorders: Cough, nasal congestion, rhinorrhoea.
Skin and subcutaneous tissue disorders: Ecchymosis.
Vascular disorders: Hypertension.
Potentially Fatal: Severe hypersensitivity (e.g. anaphylaxis).
Nasal/Parenteral: C; Intradermal: B
MonitoringParameters
Monitor for signs of anaphylaxis.
Tương tác
Decreased immunological response with immunosuppressants.
Potentially Fatal: Concomitant treatment with salicylates (e.g. aspirin) may lead to Reye’s syndrome (nasal).
Lab Interference
False-positive results in serology tests using enzyme-linked immunosorbent assays (ELISAs) method to detect antibodies to HIV-1, HTLV-1 and hepatitis C virus. May cause positive result on the rapid influenza diagnostic test for the 7 days after vaccine administration (nasal). May diminish diagnostic effect of tuberculin tests.
Tác dụng
Description: Influenza virus vaccine promotes immunity to influenza virus by inducing specific antibody production.
Synonym: flu vaccine.
Onset: Within 2 weeks of vaccination.
Duration: ≥6-8 months.
Pharmacokinetics:
Distribution: Nasal: Distributed in the nasal cavity (approx 90%), stomach (approx 3%), brain (approx 2%), and lungs (0.4%).
Bảo quản
Store between 2-8°C. Do not freeze. Protect from light.
Any unused portions should be disposed of in accordance with local requirements.
Phân loại ATC
J07BB - Influenza vaccines ; Used for active immunizations.
References
Anon. Influenza Virus Vaccine (Inactivated). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 21/06/2018.

Anon. Influenza Virus Vaccine (Live/Attenuated). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 21/06/2018.

Buckingham R (ed). Influenza Vaccines. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 21/06/2018.

Flumist Quadrivalent Intranasal Spray (MedImmune, LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 26/06/2018.

Fluzone Intradermal Quadrivalent (Sanofi Pasteur Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 26/06/2018.

Joint Formulary Committee. Influenza Vaccine. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 21/06/2018.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Vaccine, influenza từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Fluarix
  • Inflexal V
  • Vaxigrip
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in